Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Melilotus albus
White sweet clover relative of M. officinalis; similar coumarin content and venous tonic properties.
Melilotus albus, commonly known as white sweet clover, is a botanical relative of Melilotus officinalis valued for its venotonic and anti-edematous properties. Its primary active compounds include coumarin, flavonoids, and saponins, with the potential for dicoumarol formation in spoiled plant material. It is traditionally used for venous insufficiency, varicose veins, and edema, and exhibits indirect anticoagulant effects.
Coumarin, the primary active compound, is metabolized to 7-hydroxycoumarin, which exerts anti-inflammatory and anti-edematous effects by inhibiting prostaglandin synthesis and reducing capillary permeability. Flavonoids contribute to venotonic activity by enhancing venous tone and reducing venous distensibility. In spoiled plant material, coumarin is converted to dicoumarol, which inhibits vitamin K epoxide reductase, thereby interfering with the synthesis of clotting factors II, VII, IX, and X and producing an indirect anticoagulant effect.
White sweet clover relative of M. officinalis; similar coumarin content and venous tonic properties.
Melilotus albus, commonly known as white sweet clover, is a botanical relative of Melilotus officinalis valued for its venotonic and anti-edematous properties. Its primary active compounds include coumarin, flavonoids, and saponins, with the potential for dicoumarol formation in spoiled plant material. It is traditionally used for venous insufficiency, varicose veins, and edema, and exhibits indirect anticoagulant effects.
Coumarin, the primary active compound, is metabolized to 7-hydroxycoumarin, which exerts anti-inflammatory and anti-edematous effects by inhibiting prostaglandin synthesis and reducing capillary permeability. Flavonoids contribute to venotonic activity by enhancing venous tone and reducing venous distensibility. In spoiled plant material, coumarin is converted to dicoumarol, which inhibits vitamin K epoxide reductase, thereby interfering with the synthesis of clotting factors II, VII, IX, and X and producing an indirect anticoagulant effect.